Better Adherence to Antipsychotics Linked to Lower Vehicle Crash Risk

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on June 9, 2025.

By Elana Gotkine HealthDay Reporter

MONDAY, June 9, 2025 -- For drivers with schizophrenia, better adherence to antipsychotic medications is associated with lower motor vehicle crash risk, according to a study published online June 9 in CMAJ, the journal of the Canadian Medical Association.

John A. Staples, M.D., M.P.H., from the University of British Columbia in Vancouver, Canada, and colleagues performed a case-crossover study using population-based administrative health and driving data from British Columbia to examine whether antipsychotic adherence reduces the risk for a motor vehicle crash among individuals with schizophrenia. The study included individuals with schizophrenia who were involved as a driver in a police-attended motor vehicle crash during 2001 to 2016 and who filled prescriptions for antipsychotic medication as an outpatient in the two years before the crash; data were included for 1,130 eligible motor vehicle crashes.

The researchers found that the mean antipsychotic medication possession ratio was 0.69 in the 30 days before the crash (precrash interval) and 0.76 in the control interval (30-day interval ending one year before the crash). Relative to complete nonadherence, perfect adherence to antipsychotic medication was associated with half the odds of a crash (adjusted odds ratio, 0.50). Among subgroups defined by sex, age, and history of alcohol or drug use, the findings were consistent.

"Our results provide one more reason for doctors and family members to encourage people with schizophrenia to take their antipsychotics as prescribed," Staples said in a statement. "We think our results also suggest that health systems should put more resources into programs to support antipsychotic adherence among people with schizophrenia."

One author disclosed consulting for Boehringer Ingelheim, AbbVie, Newron, and Otsuka.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2025-06-10 06:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords